Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDRH Officials Reveal Top Challenges To Executing User Fee Updates

This article was originally published in The Gray Sheet

Executive Summary

Hiring and retaining the staff, adjusting the internal culture at CDRH and rebuilding relationships with industry and other public stakeholders are among FDA’s top challenges in meeting the demands of the new device user fee program, according to CDRH Director Jeffrey Shuren.

Advertisement

Related Content

User Fee Limbo: FDA Will Not Have Access To Extra Industry Funds At FY 2013 Start
Pressure Mounts On FDA After Public Release Of Surveillance Documents
FDA Subject To More Oversight Following User Fee Bill Passage
User Fee Negotiators Far Apart: Industry Seeks To Delay New Fee Levels Until FDA Improves Performance

Topics

Advertisement
UsernamePublicRestriction

Register

MT031576

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel